https://www.selleckchem.com/pr....oducts/ly3023414.htm
35 ng/mL). In addition, the effect of lycopene supplementation was significant in patients diagnosed with cardiac disorders. Overall, lycopene intake was not associated with reduced serum IGF-1 levels. However, association was significant when lycopene was administrated at doses 15 mg/d, for 12 weeks, as well as for healthy conditions and patients aged ≥60 years. In addition, lycopene supplementation exhibited potential health benefits in the management of patients with cardiac disorders. 15 mg/d, for less then 12 weeks, as we
Beğen
Yorum Yap
Paylaş
